ATE362939T1 - Dimere von thrombinpeptidderivaten - Google Patents
Dimere von thrombinpeptidderivatenInfo
- Publication number
- ATE362939T1 ATE362939T1 AT03763062T AT03763062T ATE362939T1 AT E362939 T1 ATE362939 T1 AT E362939T1 AT 03763062 T AT03763062 T AT 03763062T AT 03763062 T AT03763062 T AT 03763062T AT E362939 T1 ATE362939 T1 AT E362939T1
- Authority
- AT
- Austria
- Prior art keywords
- gly
- polypeptide
- thrombin peptide
- dimers
- asp
- Prior art date
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 7
- 108090000190 Thrombin Proteins 0.000 title abstract 3
- 229960004072 thrombin Drugs 0.000 title abstract 3
- 239000000539 dimer Substances 0.000 title abstract 2
- 229920001184 polypeptide Polymers 0.000 abstract 4
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 4
- 150000001413 amino acids Chemical group 0.000 abstract 3
- 239000012634 fragment Substances 0.000 abstract 2
- 229940117028 Thrombin receptor agonist Drugs 0.000 abstract 1
- 210000004899 c-terminal region Anatomy 0.000 abstract 1
- OXHYRVSBKWIFES-WWSDOYNLSA-N trap-14 peptide Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(N)=O)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)NC(=O)[C@@H](N)CO)C1=CC=CC=C1 OXHYRVSBKWIFES-WWSDOYNLSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/6429—Thrombin (3.4.21.5)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21005—Thrombin (3.4.21.5)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Wood Science & Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Genetics & Genomics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Physical Education & Sports Medicine (AREA)
- Cardiology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Dermatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US39357902P | 2002-07-02 | 2002-07-02 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE362939T1 true ATE362939T1 (de) | 2007-06-15 |
Family
ID=30115603
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03763062T ATE362939T1 (de) | 2002-07-02 | 2003-07-01 | Dimere von thrombinpeptidderivaten |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US7456250B2 (de) |
| EP (1) | EP1539800B1 (de) |
| JP (1) | JP4668612B2 (de) |
| AT (1) | ATE362939T1 (de) |
| AU (1) | AU2003247848B2 (de) |
| CA (1) | CA2491135A1 (de) |
| DE (1) | DE60313982T2 (de) |
| WO (1) | WO2004005317A2 (de) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2551525C (en) * | 2003-12-31 | 2013-02-19 | David W. Hobson | Pharmaceutical composition for thrombin peptide derivatives |
| WO2008036387A2 (en) * | 2006-09-22 | 2008-03-27 | Orthologic Corp. | Method of treating endothelial dysfunction |
| WO2008100567A2 (en) * | 2007-02-15 | 2008-08-21 | Orthologic Corp. | Thrombin peptide derivatives for treating fractures in osteopenic patients |
| WO2008124172A1 (en) * | 2007-04-10 | 2008-10-16 | The Board Of Regents, The University Of Texas System | Combination therapy for chronic dermal ulcers |
| WO2008124173A1 (en) * | 2007-04-10 | 2008-10-16 | The Board Of Regents, The University Of Texas System | Combination therapy for cardiac revascularization and cardiac repair |
| WO2009120304A1 (en) * | 2008-03-26 | 2009-10-01 | Orthologic Corp. | Thrombin derived peptides for smooth muscle relaxation |
| EP2268304A2 (de) * | 2008-03-26 | 2011-01-05 | Orthologic Corp. | Verfahren zur behandlung akuter myokardinfarkte |
| AU2009229395A1 (en) * | 2008-03-26 | 2009-10-01 | The Board Of Regents, The University Of Texas System | Method of treating degenerative diseases |
| WO2009120307A2 (en) * | 2008-03-26 | 2009-10-01 | Orthologic Corp. | Method of treating peripheral arterial disease |
| CU23716A1 (es) * | 2008-09-30 | 2011-10-05 | Ct Ingenieria Genetica Biotech | Péptido antagonista de la actividad de la interleucina-15 |
| CA2802176A1 (en) | 2010-06-11 | 2011-12-15 | The Board Of Regents, The University Of Texas System | Methods of mitigating effects of radiation and reducing the risk of systemic infection |
| US10220078B2 (en) | 2014-06-11 | 2019-03-05 | The Board Of Regents Of The University Of Texas System | Methods of using thrombin derivatives to treat medulloblastoma |
| JP2022527136A (ja) * | 2019-04-12 | 2022-05-30 | アファームド ファーマ，エルエルシー | 酢酸ルサラチド組成物 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5352664A (en) | 1986-10-31 | 1994-10-04 | Board Of Regents, The University Of Texas System | Thrombin derived polypeptides; compositions and methods for use |
| US6500934B1 (en) * | 1996-07-24 | 2002-12-31 | Michael Rush Lerner | Bivalent agonists for G-protein coupled receptors |
| TWI257307B (en) | 2000-07-12 | 2006-07-01 | Orthologic Corp | Pharmaceutical composition for cardiac tissue repair |
| WO2002005836A2 (en) | 2000-07-19 | 2002-01-24 | The Board Of Regents, The University Of Texas Systems | Stimulation of bone growth with thrombin peptide derivatives |
| AU2001273561B2 (en) | 2000-07-20 | 2004-10-28 | Orthologic Corp. | Stimulation of cartilage growth with agonists of the non-proteolytically activated thrombin receptor |
| JP4192093B2 (ja) | 2001-07-27 | 2008-12-03 | ザ ボード オブ リージェンツ オブ ザ ユニバーシティ オブ テキサス システム | 慢性皮膚潰瘍の治癒を促進する方法 |
| TW200407905A (en) * | 2002-11-06 | 2004-05-16 | Leadtek Research Inc | Data write-in and read-out method of flash memory and circuit thereof |
| CA2551525C (en) | 2003-12-31 | 2013-02-19 | David W. Hobson | Pharmaceutical composition for thrombin peptide derivatives |
-
2003
- 2003-07-01 JP JP2004519705A patent/JP4668612B2/ja not_active Expired - Fee Related
- 2003-07-01 WO PCT/US2003/020626 patent/WO2004005317A2/en not_active Ceased
- 2003-07-01 AT AT03763062T patent/ATE362939T1/de not_active IP Right Cessation
- 2003-07-01 AU AU2003247848A patent/AU2003247848B2/en not_active Ceased
- 2003-07-01 EP EP03763062A patent/EP1539800B1/de not_active Expired - Lifetime
- 2003-07-01 DE DE60313982T patent/DE60313982T2/de not_active Expired - Lifetime
- 2003-07-01 CA CA002491135A patent/CA2491135A1/en not_active Abandoned
-
2004
- 2004-12-30 US US11/027,795 patent/US7456250B2/en not_active Expired - Lifetime
-
2008
- 2008-10-10 US US12/287,703 patent/US7919457B2/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| US20090124550A1 (en) | 2009-05-14 |
| US7919457B2 (en) | 2011-04-05 |
| US20050153893A1 (en) | 2005-07-14 |
| AU2003247848B2 (en) | 2006-12-21 |
| JP4668612B2 (ja) | 2011-04-13 |
| DE60313982D1 (de) | 2007-07-05 |
| EP1539800A4 (de) | 2005-11-16 |
| US7456250B2 (en) | 2008-11-25 |
| JP2006507229A (ja) | 2006-03-02 |
| AU2003247848A1 (en) | 2004-01-23 |
| EP1539800B1 (de) | 2007-05-23 |
| CA2491135A1 (en) | 2004-01-15 |
| DE60313982T2 (de) | 2008-01-17 |
| WO2004005317A3 (en) | 2004-09-30 |
| EP1539800A2 (de) | 2005-06-15 |
| WO2004005317A2 (en) | 2004-01-15 |
| AU2003247848C1 (en) | 2004-01-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE368053T1 (de) | Antimikrobielle peptide | |
| DE60030450D1 (de) | Von MUC-1 abgeleitete Peptide | |
| DK1265914T3 (da) | WNT-1-relaterede polypeptider og nukleinsyrer, der koder for samme | |
| ATE362939T1 (de) | Dimere von thrombinpeptidderivaten | |
| DK0662827T4 (da) | Terapeutiske og diagnostiske fremgangsmåder og sammensætninger baseret på Notch-proteiner og nucleinsyrer | |
| KR970702917A (ko) | Lag-3의 가용성 폴리펩타이드 절편 및 생산 방법, 치료 조성물, 항-이디오타입 항체 | |
| NO20063026L (no) | Antistoffer | |
| DE69129865D1 (de) | Osteogene peptide | |
| BR0010720A (pt) | Peptìdeos de neisseria antigênicos | |
| WO2004014937A3 (en) | Thrombin peptide derivatives | |
| DE69733773D1 (de) | Fas ANTIGEN-DERIVATE | |
| DE69840024D1 (de) | Antimikrobielle Peptide, abstammend von Ubiquicidin | |
| ATE432287T1 (de) | Peptidfragmente mit den zelltod verhindernder aktivität | |
| CY1109946T1 (el) | Τροποποιημενα πεπτιδια και η χρηση τους για τη θεραπεια αυτοανοσων νοσων | |
| ATE374246T1 (de) | Polypeptidfragmente mit einem c-terminalen teil von katalase aus helicobacter | |
| ATE290088T1 (de) | Verfahren zur spaltung eines chimeren proteins mittels eines 'processing'-enzyms | |
| ATE291033T1 (de) | Therapeutische peptide | |
| DE60036676D1 (de) | G-protein-gekoppelter rezeptor-ähnliche proteine | |
| ATE432985T1 (de) | Polypeptide mit aktivität der stimulierung von neutrophilen | |
| WO2003044159A9 (en) | Zinc finger proteins, polynucleotides encoding same and antibodies thereto | |
| EP1225183A3 (de) | Humaner G-Protein gekoppelter Rezeptor | |
| DE69927524D1 (de) | Topoisomerase-ii inhibitoren | |
| WO2005019407A3 (en) | Polynucleotides, polypeptides and antibodies and use thereof in treating tsg101-associated diseases | |
| DK1158050T3 (da) | Human cysteinyl-leukotrienreceptor (CysLT2) | |
| WO2002097036A3 (en) | Compositions and methods for adipose abundant protein |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |